Swiss Diabetes Registry for patients with diabetes
Official title: Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland
Run by Insel Gruppe AG, University Hospital Bern · NCT01179815 · Data updated 2026-11-12
This study is collecting information from diabetes patients in Switzerland to see how well their treatment matches current guidelines and to improve care for everyone with diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 4 sites (Bern and 3 other locations) |
| Status | Recruiting |
| Started | January 2010 |
| Main results expected | January 2099 |
| Study ends | January 2099 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT01179815 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old diagnosed with any form of diabetes mellitus.
✕Probably not a fit
Patients with gestational diabetes or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study that aims to collect comprehensive data from nearly all patients with diabetes mellitus treated at participating centers in Switzerland. By utilizing an internet-based electronic database, the study evaluates the current standard of care and treatment outcomes for patients with type 1, type 2, and other forms of diabetes. This observational study seeks to identify discrepancies between recommended treatment guidelines and actual patient care in both specialty clinics and community settings. The findings will help inform future diabetes management strategies and improve patient well-being.
Why it matters
Potential benefit: If successful, this study could lead to improved diabetes management and better health outcomes for patients.
How similar studies have gone: Other observational studies have shown success in identifying gaps in diabetes care, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Diagnosis of diabetes mellitus according to ADA criteria * Informed consent Exclusion Criteria: * Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (\<1 year) will be excluded
Where it's running
-
Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern
Bern, Switzerland Recruiting -
Service d'endocrinologie, diabétologie et métabolisme
Lausanne, Switzerland Recruiting -
Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen
Sankt Gallen, Switzerland Recruiting -
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Michael Brändle, Prof. — Div. of Endocrinology, Diabetes and Clinical Nutrition, Kantonsspital St. Gallen
- Study coordinator: Markus Laimer, PD Dr. med.
- Email: Markus.Laimer@insel.ch
- Phone: +41 31 632 30 62
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.